Commentary: netazepide for gastric acid suppression – another kid on the block? (Englisch)
- Neue Suche nach: Metz, D. C.
- Neue Suche nach: Metz, D. C.
In:
Alimentary Pharmacology & Therapeutics
;
36
, 3
;
294-295
;
2012
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Commentary: netazepide for gastric acid suppression – another kid on the block?
-
Beteiligte:Metz, D. C. ( Autor:in )
-
Erschienen in:Alimentary Pharmacology & Therapeutics ; 36, 3 ; 294-295
-
Verlag:
-
Erscheinungsdatum:01.08.2012
-
Format / Umfang:2 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 36, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 213
-
Systematic review: the applications of nanotechnology in gastroenterologyBrakmane, G. / Winslet, M. / Seifalian, A. M. et al. | 2012
- 222
-
Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infectionCammarota, G. / Sanguinetti, M. / Gallo, A. / Posteraro, B. et al. | 2012
- 231
-
Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate ‐ a placebo‐controlled studyNseir, W. / Diab, H. / Mahamid, M. / Abu‐Elheja, O. / Samara, M. / Abid, A. / Mograbi, J. et al. | 2012
- 239
-
Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel diseaseJuillerat, P. / Schneeweiss, S. / Cook, E. F. / Ananthakrishnan, A. N. / Mogun, H. / Korzenik, J. R. et al. | 2012
- 248
-
Treatment of new‐onset ulcerative colitis and ulcerative proctitis: a retrospective studyRichter, J. M. / Kushkuley, S. / Barrett, J. A. / Oster, G. et al. | 2012
- 257
-
Potentially curative treatment in patients with hepatocellular cancer—results from the liver cancer research networkKanwal, F. / Befeler, A. / Chari, R. S. / Marrero, J. / Kahn, J. / Afdhal, N. / Morgan, T. / Roberts, L. / Mohanty, S. R. / Schwartz, J. et al. | 2012
- 266
-
Ursodeoxycholic acid therapy in cystic fibrosis liver disease – a retrospective long‐term follow‐up case‐control studyKappler, M. / Espach, C. / Schweiger‐Kabesch, A. / Lang, T. / Hartl, D. / Hector, A. / Glasmacher, C. / Griese, M. et al. | 2012
- 274
-
Tioguanine in the treatment of refractory coeliac disease – a single centre experienceTack, G. J. / van Asseldonk, D. P. / van Wanrooij, R. L. J. / van Bodegraven, A. A. / Mulder, C. J. et al. | 2012
- 282
-
Columnar‐lined oesophagus without intestinal metaplasia: results from a cohort with a mean follow‐up of 7 yearsDias Pereira, A. / Chaves, P. et al. | 2012
- 290
-
Commentary: risk of colorectal adenomas and advanced neoplasia in Hispanic, black and white patientsCollins, P. D. et al. | 2012
- 291
-
Commentary: changing aetiology of peptic ulcersGoh, K.‐L. / Chan, W.‐K. et al. | 2012
- 292
-
Commentary: changing aetiology of peptic ulcers – author's replyMusumba, C. / Pritchard, D. M. / Pirmohamed, M. et al. | 2012
- 293
-
Commentary: new tools to assess hepatic steatosis – what do we want to measure?Yu, Z. / Wong, V. W.‐S. et al. | 2012
- 294
-
Commentary: new tools to assess hepatic steatosis – what do we want to measure? Author's replyLoomba, R. et al. | 2012
- 294
-
Commentary: netazepide for gastric acid suppression – another kid on the block?Metz, D. C. et al. | 2012
- 296
-
Letter: ulcerative colitis in patients transplanted for primary sclerosing cholangitisCholongitas, E. / Burroughs, A. K. et al. | 2012
- 297
-
Letter: surgery for ulcerative colitis mostly follows anti‐TNF drugs ‐ a new ‘therapeutic package’?Barreiro‐de Acosta, M. / Gisbert, J. P. et al. | 2012
- 297
-
Letter: ulcerative colitis in patients transplanted for primary sclerosing cholangitis – authors’ replyNavaneethan, U. / Venkatesh, P. G. K. / Kiran, R. P. et al. | 2012
- 298
-
Letter: surgery for ulcerative colitis mostly follows anti‐TNF drugs ‐ a new ‘therapeutic package'? Authors' replyNørgård, B. M. / on behalf of co‐authors et al. | 2012